For citations:
Lila A.M., Zyryanov S.K., Dyakov I.N. harmacoeconomic feasibility of using the drug upadacitinib in patients with rheumatoid arthritis in the healthcare system of the Russian Federation. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2020;(3):40-51. (In Russ.) https://doi.org/10.37489/2588-0519-2020-3-40-51
Email this article 